# GrowthX Capital

GrowthX Capital is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** www.growthx.com
- **LinkedIn:** https://www.linkedin.com/company/growthx

## Regulatory record

- **Reports private funds:** No

## About

GrowthX helps B2B founders turn product momentum into revenue growth through expert coaching programs and a proprietary AI platform called GrowthX Go. The firm combines human sales coaching with AI execution so founders can convert GTM activity into revenue. It works with B2B founders as well as investors, economic developers, foundations, and ecosystem leaders who want more companies to turn innovation into revenue.

## Sectors

- Enterprise Software
- AI/ML
- FinTech
- Digital Health
- ClimateTech

## Questions

### How does GrowthX Capital source proprietary deal flow?

The firm's enterprise-access model is its primary sourcing advantage. By acting as a revenue-acceleration partner for B2B startups, GrowthX builds direct relationships with technical founders who are actively seeking corporate pilots and design partners. This network effect generates inbound deal flow from founders attracted to the firm's distribution-first value proposition.

### Does GrowthX Capital participate in fund commitments or only direct deals?

Based on its public positioning, GrowthX Capital invests directly into operating companies at the seed and pre-seed stages. There is no indication that the firm makes fund-of-fund commitments or participates as a limited partner in other venture funds. Its model is built around direct minority equity stakes coupled with enterprise-access programming.

### Which sectors does GrowthX Capital explicitly avoid?

GrowthX Capital does not publish a formal exclusion list. Given its enterprise distribution model, the firm is unlikely to pursue consumer-facing startups, hardware-dependent businesses, or life sciences companies that require FDA-approval pathways — sectors where corporate customer access is not the primary growth catalyst. Its portfolio concentrates on enterprise software, applied AI, FinTech, digital health platforms, and climate-adjacent data tools.

## Related profiles

- [GrowthWorks Capital](https://altss.com/profile/growthworks-capital)
- [Grow Ventures Partners](https://altss.com/profile/grow-ventures-partners)

---

Last updated: 2026-08-11T15:06:57.816Z

Canonical page: https://altss.com/profile/growthx-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology